Cynata Therapeutics Limited (ASX:CYP)
Australia
· Delayed Price · Currency is AUD 0.1950
+0.0050 (2.63%)
May 23, 2025, 3:32 PM AEST
Cynata Therapeutics Revenue
Cynata Therapeutics had revenue of 1.97M AUD in the half year ending December 31, 2024, with 9.39% growth. This brings the company's revenue in the last twelve months to 1.74M, down -27.47% year-over-year. In the fiscal year ending June 30, 2024, Cynata Therapeutics had annual revenue of 2.32M with 39.98% growth.
Revenue (ttm)
1.74M
Revenue Growth
-27.47%
P/S Ratio
24.67
Revenue / Employee
870.03K
Employees
2
Market Cap
42.93M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 2.32M | 661.33K | 39.98% |
| Jun 30, 2023 | 1.65M | -6.12M | -78.71% |
| Jun 30, 2022 | 7.77M | 6.22M | 402.60% |
| Jun 30, 2021 | 1.55M | -5.47M | -77.95% |
| Jun 30, 2020 | 7.01M | 5.70M | 435.83% |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
| Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 24.61B |
| Pro Medicus | 184.58M |
| Cochlear | 2.31B |
| Sonic Healthcare | 9.33B |
| Telix Pharmaceuticals | 783.21M |
| Ramsay Health Care | 17.12B |
| Ansell | 3.00B |
| Regis Healthcare | 1.10B |
Cynata Therapeutics News
- 3 months ago - Cynata Therapeutics Limited (CYYNF) Investor Webinar Transcript - Seeking Alpha
- 5 years ago - Mesoblast Needs A Solution To MSC Scalability Issues - Cynata Therapeutics Has An Answer - Seeking Alpha